S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Better Than Oil Stocks (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Better Than Oil Stocks (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Better Than Oil Stocks (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
Better Than Oil Stocks (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Price, News & Analysis

$1.17
-0.12 (-9.30%)
(As of 02/12/2024)
Today's Range
$1.17
$1.17
50-Day Range
$1.17
$1.29
52-Week Range
$0.96
$1.59
Volume
2,100 shs
Average Volume
1,300 shs
Market Capitalization
$763.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PHGUF stock logo

About Pharming Group Stock (OTCMKTS:PHGUF)

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

PHGUF Stock Price History

PHGUF Stock News Headlines

Pharming Group NV (PHAR)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Pharming Group Projects 2023 Total Revenues To Rise 19%
Elon Musk's "Project Dojo" is a Game-Changer
Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation.
H.C. Wainwright Keeps Their Buy Rating on Pharming Group (PHAR)
Pharming Group NV American Depositary Shares Repr 10 Shs Reg S
Pharming Group N.V. reports Q2 results
RBC Capital Sticks to Their Buy Rating for Pharming Group (PHGUF)
See More Headlines
Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2015
Today
2/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHGUF
CIK
N/A
Employees
332
Year Founded
N/A

Profitability

Net Income
$13.67 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$205.62 million
Cash Flow
$0.04 per share
Book Value
$0.31 per share

Miscellaneous

Free Float
N/A
Market Cap
$763.32 million
Optionable
Not Optionable
Beta
1.11
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Sijmen de Vries M.B.A. (Age 65)
    M.D., President, CEO & Executive Director
    Comp: $1.18M
  • Mr. Jeroen Wakkerman (Age 55)
    Chief Financial Officer
  • Ms. Mireille Sanders M.Sc. (Age 56)
    Chief Operations Officer
  • Susanne Embleton
    Investor Relations Manager
  • Mr. Ruud Van Outersterp (Age 60)
    Chief Ethics & Compliance Officer
  • Dr. Anurag Relan M.D. (Age 52)
    MPH, Chief Medical Officer
  • Mr. Stephen Toor (Age 53)
    Chief Commercial Officer & GM Americas
  • Dr. Alexander Breidenbach M.B.A.
    Chief Business Officer
  • Dr. Bruno M. L. Giannetti (Age 72)
    Consultant














PHGUF Stock Analysis - Frequently Asked Questions

How have PHGUF shares performed in 2024?

Pharming Group's stock was trading at $1.1750 at the start of the year. Since then, PHGUF shares have decreased by 0.4% and is now trading at $1.17.
View the best growth stocks for 2024 here
.

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) announced its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a negative net margin of 10.06% and a negative trailing twelve-month return on equity of 10.76%.

How do I buy shares of Pharming Group?

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PHGUF) was last updated on 2/26/2024 by MarketBeat.com Staff